The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Large Volume Parenteral (LVP) Market Research Report 2025
Synopsis
The global market for Large Volume Parenteral (LVP) was valued at US$ 11230 million in the year 2024 and is projected to reach a revised size of US$ 15480 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Large volume parenteral preparations or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml, with the most common sizes being 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml, with instructions usually recommending large volumes for administration. Parenteral preparations are sterile solid dosage forms or non-pyrogenic liquids containing one or more active ingredients in single-dose or multi-dose containers. They are intended to be administered by infusion, implant or injection into the body.
Global key players of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, etc. The top five players hold a share about 68%. Asia-Pacific is the world's largest market for Large Volume Parenteral (LVP) and holds a share about xx%, followed by Europe and North America, with share about 25% and 24%, separately. In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%. In terms of application, Basic Infusion is the largest field with a share about 63 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).
The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter Healthcare
Kelun Group
Fresenius
B. Braun
Ostuka Pharmaceutical
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BML Parenteral Drugs
Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Large Volume Parenteral (LVP) was valued at US$ 11230 million in the year 2024 and is projected to reach a revised size of US$ 15480 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Large volume parenteral preparations or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml, with the most common sizes being 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml, with instructions usually recommending large volumes for administration. Parenteral preparations are sterile solid dosage forms or non-pyrogenic liquids containing one or more active ingredients in single-dose or multi-dose containers. They are intended to be administered by infusion, implant or injection into the body.
Global key players of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, etc. The top five players hold a share about 68%. Asia-Pacific is the world's largest market for Large Volume Parenteral (LVP) and holds a share about xx%, followed by Europe and North America, with share about 25% and 24%, separately. In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%. In terms of application, Basic Infusion is the largest field with a share about 63 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).
The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter Healthcare
Kelun Group
Fresenius
B. Braun
Ostuka Pharmaceutical
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BML Parenteral Drugs
Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Definition
1.2 Large Volume Parenteral (LVP) by Type
1.2.1 Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) by Application
1.3.1 Global Large Volume Parenteral (LVP) Market Value by Application (2024 VS 2031)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2020-2031
1.4.2 Global Large Volume Parenteral (LVP) Sales 2020-2031
1.4.3 Global Large Volume Parenteral (LVP) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Large Volume Parenteral (LVP), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
2.7 Global Key Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
2.8 Global Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.8.1 Global Large Volume Parenteral (LVP) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.8.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Large Volume Parenteral (LVP) Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Large Volume Parenteral (LVP) Sales by Region: 2020-2031
3.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2020-2025
3.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2026-2031
3.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2020-2031
3.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2020-2025
3.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2026-2031
3.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2020-2031)
3.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2020-2031)
3.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2020-2031)
3.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2020-2031)
3.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type (2020-2031)
4.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2020-2025)
4.1.2 Global Large Volume Parenteral (LVP) Sales by Type (2026-2031)
4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2020-2031)
4.2 Global Large Volume Parenteral (LVP) Revenue by Type (2020-2031)
4.2.1 Global Large Volume Parenteral (LVP) Revenue by Type (2020-2025)
4.2.2 Global Large Volume Parenteral (LVP) Revenue by Type (2026-2031)
4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2020-2031)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Large Volume Parenteral (LVP) Sales by Application (2020-2031)
5.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2020-2025)
5.1.2 Global Large Volume Parenteral (LVP) Sales by Application (2026-2031)
5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2031)
5.2 Global Large Volume Parenteral (LVP) Revenue by Application (2020-2031)
5.2.1 Global Large Volume Parenteral (LVP) Revenue by Application (2020-2025)
5.2.2 Global Large Volume Parenteral (LVP) Revenue by Application (2026-2031)
5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2020-2031)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Company Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Group
6.2.1 Kelun Group Company Information
6.2.2 Kelun Group Description and Business Overview
6.2.3 Kelun Group Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kelun Group Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Group Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Company Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Ostuka Pharmaceutical
6.5.1 Ostuka Pharmaceutical Company Information
6.5.2 Ostuka Pharmaceutical Description and Business Overview
6.5.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Ostuka Pharmaceutical Recent Developments/Updates
6.6 ICU Medical
6.6.1 ICU Medical Company Information
6.6.2 ICU Medical Description and Business Overview
6.6.3 ICU Medical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ICU Medical Large Volume Parenteral (LVP) Product Portfolio
6.6.5 ICU Medical Recent Developments/Updates
6.7 SSY Group
6.7.1 SSY Group Company Information
6.7.2 SSY Group Description and Business Overview
6.7.3 SSY Group Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SSY Group Large Volume Parenteral (LVP) Product Portfolio
6.7.5 SSY Group Recent Developments/Updates
6.8 Shuang Hor
6.8.1 Shuang Hor Company Information
6.8.2 Shuang Hor Description and Business Overview
6.8.3 Shuang Hor Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shuang Hor Large Volume Parenteral (LVP) Product Portfolio
6.8.5 Shuang Hor Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Company Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 PiSA Farmacéutica
6.10.1 PiSA Farmacéutica Company Information
6.10.2 PiSA Farmacéutica Description and Business Overview
6.10.3 PiSA Farmacéutica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PiSA Farmacéutica Large Volume Parenteral (LVP) Product Portfolio
6.10.5 PiSA Farmacéutica Recent Developments/Updates
6.11 Huaren Pharmaceutical
6.11.1 Huaren Pharmaceutical Company Information
6.11.2 Huaren Pharmaceutical Description and Business Overview
6.11.3 Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Huaren Pharmaceutical Recent Developments/Updates
6.12 Chimin
6.12.1 Chimin Company Information
6.12.2 Chimin Description and Business Overview
6.12.3 Chimin Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Chimin Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Chimin Recent Developments/Updates
6.13 Beximco Pharma
6.13.1 Beximco Pharma Company Information
6.13.2 Beximco Pharma Description and Business Overview
6.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Beximco Pharma Recent Developments/Updates
6.14 Albert David
6.14.1 Albert David Company Information
6.14.2 Albert David Description and Business Overview
6.14.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.14.5 Albert David Recent Developments/Updates
6.15 PSI Ltd
6.15.1 PSI Ltd Company Information
6.15.2 PSI Ltd Description and Business Overview
6.15.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.15.5 PSI Ltd Recent Developments/Updates
6.16 Ozon Pharmaceuticals
6.16.1 Ozon Pharmaceuticals Company Information
6.16.2 Ozon Pharmaceuticals Description and Business Overview
6.16.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.16.5 Ozon Pharmaceuticals Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Company Information
6.17.2 BML Parenteral Drugs Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Parenteral (LVP) Industry Chain Analysis
7.2 Large Volume Parenteral (LVP) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Parenteral (LVP) Production Mode & Process Analysis
7.4 Large Volume Parenteral (LVP) Sales and Marketing
7.4.1 Large Volume Parenteral (LVP) Sales Channels
7.4.2 Large Volume Parenteral (LVP) Distributors
7.5 Large Volume Parenteral (LVP) Customer Analysis
8 Large Volume Parenteral (LVP) Market Dynamics
8.1 Large Volume Parenteral (LVP) Industry Trends
8.2 Large Volume Parenteral (LVP) Market Drivers
8.3 Large Volume Parenteral (LVP) Market Challenges
8.4 Large Volume Parenteral (LVP) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Large Volume Parenteral (LVP) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Large Volume Parenteral (LVP) Sales (Million Units) of Key Manufacturers (2020-2025)
Table 5. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Large Volume Parenteral (LVP), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
Table 12. Global Key Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Large Volume Parenteral (LVP) Sales by Region (2020-2025) & (Million Units)
Table 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2020-2025)
Table 19. Global Large Volume Parenteral (LVP) Sales by Region (2026-2031) & (Million Units)
Table 20. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2026-2031)
Table 21. Global Large Volume Parenteral (LVP) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2020-2025)
Table 23. Global Large Volume Parenteral (LVP) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2026-2031)
Table 25. North America Large Volume Parenteral (LVP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 27. North America Large Volume Parenteral (LVP) Sales by Country (2026-2031) & (Million Units)
Table 28. North America Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Large Volume Parenteral (LVP) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Large Volume Parenteral (LVP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 32. Europe Large Volume Parenteral (LVP) Sales by Country (2026-2031) & (Million Units)
Table 33. Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Large Volume Parenteral (LVP) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2020-2025) & (Million Units)
Table 37. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2026-2031) & (Million Units)
Table 38. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Large Volume Parenteral (LVP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 42. Latin America Large Volume Parenteral (LVP) Sales by Country (2026-2031) & (Million Units)
Table 43. Latin America Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Large Volume Parenteral (LVP) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 47. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2026-2031) & (Million Units)
Table 48. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Large Volume Parenteral (LVP) Sales (Million Units) by Type (2020-2025)
Table 51. Global Large Volume Parenteral (LVP) Sales (Million Units) by Type (2026-2031)
Table 52. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2020-2025)
Table 53. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2026-2031)
Table 54. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2020-2025)
Table 57. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2026-2031)
Table 58. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2020-2025)
Table 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2026-2031)
Table 60. Global Large Volume Parenteral (LVP) Sales (Million Units) by Application (2020-2025)
Table 61. Global Large Volume Parenteral (LVP) Sales (Million Units) by Application (2026-2031)
Table 62. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Table 63. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2026-2031)
Table 64. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2020-2025)
Table 67. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2026-2031)
Table 68. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2020-2025)
Table 69. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2026-2031)
Table 70. Baxter Healthcare Company Information
Table 71. Baxter Healthcare Description and Business Overview
Table 72. Baxter Healthcare Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 73. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 74. Baxter Healthcare Recent Developments/Updates
Table 75. Kelun Group Company Information
Table 76. Kelun Group Description and Business Overview
Table 77. Kelun Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 78. Kelun Group Large Volume Parenteral (LVP) Product
Table 79. Kelun Group Recent Developments/Updates
Table 80. Fresenius Company Information
Table 81. Fresenius Description and Business Overview
Table 82. Fresenius Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 83. Fresenius Large Volume Parenteral (LVP) Product
Table 84. Fresenius Recent Developments/Updates
Table 85. B. Braun Company Information
Table 86. B. Braun Description and Business Overview
Table 87. B. Braun Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 88. B. Braun Large Volume Parenteral (LVP) Product
Table 89. B. Braun Recent Developments/Updates
Table 90. Ostuka Pharmaceutical Company Information
Table 91. Ostuka Pharmaceutical Description and Business Overview
Table 92. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 93. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 94. Ostuka Pharmaceutical Recent Developments/Updates
Table 95. ICU Medical Company Information
Table 96. ICU Medical Description and Business Overview
Table 97. ICU Medical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 98. ICU Medical Large Volume Parenteral (LVP) Product
Table 99. ICU Medical Recent Developments/Updates
Table 100. SSY Group Company Information
Table 101. SSY Group Description and Business Overview
Table 102. SSY Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 103. SSY Group Large Volume Parenteral (LVP) Product
Table 104. SSY Group Recent Developments/Updates
Table 105. Shuang Hor Company Information
Table 106. Shuang Hor Description and Business Overview
Table 107. Shuang Hor Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 108. Shuang Hor Large Volume Parenteral (LVP) Product
Table 109. Shuang Hor Recent Developments/Updates
Table 110. Cisen Pharmaceutical Company Information
Table 111. Cisen Pharmaceutical Description and Business Overview
Table 112. Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 113. Cisen Pharmaceutical Large Volume Parenteral (LVP) Product
Table 114. Cisen Pharmaceutical Recent Developments/Updates
Table 115. PiSA Farmacéutica Company Information
Table 116. PiSA Farmacéutica Description and Business Overview
Table 117. PiSA Farmacéutica Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 118. PiSA Farmacéutica Large Volume Parenteral (LVP) Product
Table 119. PiSA Farmacéutica Recent Developments/Updates
Table 120. Huaren Pharmaceutical Company Information
Table 121. Huaren Pharmaceutical Description and Business Overview
Table 122. Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 123. Huaren Pharmaceutical Large Volume Parenteral (LVP) Product
Table 124. Huaren Pharmaceutical Recent Developments/Updates
Table 125. Chimin Company Information
Table 126. Chimin Description and Business Overview
Table 127. Chimin Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 128. Chimin Large Volume Parenteral (LVP) Product
Table 129. Chimin Recent Developments/Updates
Table 130. Beximco Pharma Company Information
Table 131. Beximco Pharma Description and Business Overview
Table 132. Beximco Pharma Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 133. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 134. Beximco Pharma Recent Developments/Updates
Table 135. Albert David Company Information
Table 136. Albert David Description and Business Overview
Table 137. Albert David Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 138. Albert David Large Volume Parenteral (LVP) Product
Table 139. Albert David Recent Developments/Updates
Table 140. PSI Ltd Company Information
Table 141. PSI Ltd Description and Business Overview
Table 142. PSI Ltd Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 143. PSI Ltd Large Volume Parenteral (LVP) Product
Table 144. PSI Ltd Recent Developments/Updates
Table 145. Ozon Pharmaceuticals Company Information
Table 146. Ozon Pharmaceuticals Description and Business Overview
Table 147. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 148. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
Table 149. Ozon Pharmaceuticals Recent Developments/Updates
Table 150. BML Parenteral Drugs Company Information
Table 151. BML Parenteral Drugs Description and Business Overview
Table 152. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 153. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
Table 154. BML Parenteral Drugs Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Large Volume Parenteral (LVP) Distributors List
Table 158. Large Volume Parenteral (LVP) Customers List
Table 159. Large Volume Parenteral (LVP) Market Trends
Table 160. Large Volume Parenteral (LVP) Market Drivers
Table 161. Large Volume Parenteral (LVP) Market Challenges
Table 162. Large Volume Parenteral (LVP) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Large Volume Parenteral (LVP)
Figure 2. Global Large Volume Parenteral (LVP) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Large Volume Parenteral (LVP) Market Share by Type: 2024 & 2031
Figure 4. Soft Bag LVP Product Picture
Figure 5. Plastic Bottle LVP Product Picture
Figure 6. Glass Bottle LVP Product Picture
Figure 7. Global Large Volume Parenteral (LVP) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Large Volume Parenteral (LVP) Market Share by Application: 2024 & 2031
Figure 9. Basic Infusion
Figure 10. Therapeutic Infusion
Figure 11. Nutritious Infusion
Figure 12. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Large Volume Parenteral (LVP) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Large Volume Parenteral (LVP) Sales (2020-2031) & (Million Units)
Figure 15. Global Large Volume Parenteral (LVP) Average Price (US$/K Units) & (2020-2031)
Figure 16. Large Volume Parenteral (LVP) Report Years Considered
Figure 17. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2024
Figure 18. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Large Volume Parenteral (LVP) Players: Market Share by Revenue in Large Volume Parenteral (LVP) in 2024
Figure 20. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2031)
Figure 23. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2031)
Figure 27. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2020-2031)
Figure 35. China Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Large Volume Parenteral (LVP) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Large Volume Parenteral (LVP) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Large Volume Parenteral (LVP) by Type (2020-2031)
Figure 56. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2020-2031)
Figure 57. Global Sales Market Share of Large Volume Parenteral (LVP) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Large Volume Parenteral (LVP) by Application (2020-2031)
Figure 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2020-2031)
Figure 60. Large Volume Parenteral (LVP) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
